Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells

Abstract Background Lidocaine is a traditional local anesthetic, which has been reported to trigger apoptosis through the mitochondrial pathway, independent of death receptor signaling. Cuproptosis is a copper triggered mitochondrial cell death mode. In this study, we explored the biological effects...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Liu, Yi Yu, Yi He, Meihong Lv
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13533-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585610998579200
author Wei Liu
Yi Yu
Yi He
Meihong Lv
author_facet Wei Liu
Yi Yu
Yi He
Meihong Lv
author_sort Wei Liu
collection DOAJ
description Abstract Background Lidocaine is a traditional local anesthetic, which has been reported to trigger apoptosis through the mitochondrial pathway, independent of death receptor signaling. Cuproptosis is a copper triggered mitochondrial cell death mode. In this study, we explored the biological effects of lidocaine on cuproptosis in Hep-2 cells and studied the relevant mechanisms. Methods quantitative RT-PCR was used to measure the expression level of long noncoding RNA (IncRNA) DNMBP-AS1. DNMBP-AS1 siRNA (si-DNMBP-AS1) were transfected into Hep-2 cells to verify the roles of DNMBP-AS1 in cuproptosis. 24 h treatment with 20 nM elesclomol and 2 µM CuCl2 was performed to promote the occurrence of Cuproptosis. Cell proliferation, migration and apoptosis assays ware utilized to analyze biological effect of lidocaine and DNMBP-AS1 on Hep-2 cells. Active caspase-3 were also determined after treatment. Results DNMBP-AS1 was significantly upregulated during cuproptosis in Hep-2 cells. The si-DNMBP-AS1 significantly increased the cell viability with nonactivated caspase-3, promoted the cell migration and suppress the cuproptosis. Lidocaine was cytotoxic to the Hep-2 cells in a dose- and time-dependent manner. Exposure to 10 µM of lidocaine for 24 h did not reduce the viability or activated the caspase-3, but significantly increased the expression of DNMBP-AS1, and promote the cuproptosis. Anymore, si-DNMBP-AS1 reversed the pro-cuproptosis function of lidocaine. Conclusions lidocaine was cytotoxic to Hep-2 cells in a time- and dose-dependent manner, promoted the cuproptosis through up-regulating DNMBP-AS1. The results of this study offered initial optimism that lidocaine could be used in an adjuvant or neoadjuvant fashion in cancer treatment.
format Article
id doaj-art-01161f2809a54453a379548044faea20
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-01161f2809a54453a379548044faea202025-01-26T12:38:18ZengBMCBMC Cancer1471-24072025-01-012511610.1186/s12885-025-13533-1Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cellsWei Liu0Yi Yu1Yi He2Meihong Lv3Department of Otolaryngology, the Second Affiliated Hospital of Dalian Medical UniversityGeneral Surgery, the First Affiliated Hospital of Dalian Medical UniversityDepartment of Urology, the Second Affiliated Hospital of Dalian Medical UniversityDepartment of Anesthesiology, the First Affiliated Hospital of Dalian Medical UniversityAbstract Background Lidocaine is a traditional local anesthetic, which has been reported to trigger apoptosis through the mitochondrial pathway, independent of death receptor signaling. Cuproptosis is a copper triggered mitochondrial cell death mode. In this study, we explored the biological effects of lidocaine on cuproptosis in Hep-2 cells and studied the relevant mechanisms. Methods quantitative RT-PCR was used to measure the expression level of long noncoding RNA (IncRNA) DNMBP-AS1. DNMBP-AS1 siRNA (si-DNMBP-AS1) were transfected into Hep-2 cells to verify the roles of DNMBP-AS1 in cuproptosis. 24 h treatment with 20 nM elesclomol and 2 µM CuCl2 was performed to promote the occurrence of Cuproptosis. Cell proliferation, migration and apoptosis assays ware utilized to analyze biological effect of lidocaine and DNMBP-AS1 on Hep-2 cells. Active caspase-3 were also determined after treatment. Results DNMBP-AS1 was significantly upregulated during cuproptosis in Hep-2 cells. The si-DNMBP-AS1 significantly increased the cell viability with nonactivated caspase-3, promoted the cell migration and suppress the cuproptosis. Lidocaine was cytotoxic to the Hep-2 cells in a dose- and time-dependent manner. Exposure to 10 µM of lidocaine for 24 h did not reduce the viability or activated the caspase-3, but significantly increased the expression of DNMBP-AS1, and promote the cuproptosis. Anymore, si-DNMBP-AS1 reversed the pro-cuproptosis function of lidocaine. Conclusions lidocaine was cytotoxic to Hep-2 cells in a time- and dose-dependent manner, promoted the cuproptosis through up-regulating DNMBP-AS1. The results of this study offered initial optimism that lidocaine could be used in an adjuvant or neoadjuvant fashion in cancer treatment.https://doi.org/10.1186/s12885-025-13533-1LidocaineHep-2 cellsCuproptosisIncRNA DNMBP-AS1
spellingShingle Wei Liu
Yi Yu
Yi He
Meihong Lv
Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
BMC Cancer
Lidocaine
Hep-2 cells
Cuproptosis
IncRNA DNMBP-AS1
title Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
title_full Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
title_fullStr Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
title_full_unstemmed Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
title_short Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells
title_sort lidocaine could promote the cuproptosis through up regulating the long noncoding rna dnmbp as1 in hep 2 cells
topic Lidocaine
Hep-2 cells
Cuproptosis
IncRNA DNMBP-AS1
url https://doi.org/10.1186/s12885-025-13533-1
work_keys_str_mv AT weiliu lidocainecouldpromotethecuproptosisthroughupregulatingthelongnoncodingrnadnmbpas1inhep2cells
AT yiyu lidocainecouldpromotethecuproptosisthroughupregulatingthelongnoncodingrnadnmbpas1inhep2cells
AT yihe lidocainecouldpromotethecuproptosisthroughupregulatingthelongnoncodingrnadnmbpas1inhep2cells
AT meihonglv lidocainecouldpromotethecuproptosisthroughupregulatingthelongnoncodingrnadnmbpas1inhep2cells